Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Blood|September 10, 2005
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokinesAndrea Anichini, Roberta Mortarini, Luca Romagnoli, et al.
Plos One|April 27, 2013
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cellsCarmelo Carlo-Stella, Silvia L Locatelli, Arianna Giacomini, et al.
American Journal of Blood Research|July 5, 2012
Detection of minimal residual disease in hematopoietic progenitor cell harvests: lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphomaMichele Magni, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Angiogenesis|April 23, 2013
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cellsArianna Giacomini, Marco Righi, Loredana Cleris, et al.
Blood|May 3, 2002
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliMassimo Di Nicola, Carmelo Carlo-Stella, Michele Magni, et al.
Haematologica|August 30, 2008
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cellsRoberta Zappasodi, Massimo Di Nicola, Carmelo Carlo-Stella, et al.
Leukemia & Lymphoma|June 10, 2010
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experienceSimonetta Viviani, Massimo Di Nicola, Valeria Bonfante, et al.
Haematologica|December 23, 2003
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionMassimo Di Nicola, Sara Napoli, Andrea Anichini, et al.
International Journal of Cancer|May 29, 2014
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulationMarzia Pennati, Stefania Sbarra, Michelandrea De Cesare, et al.
British Journal of Haematology|September 9, 2004
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adultsMassimo Di Nicola, Carmelo Carlo-Stella, Jacopo Mariotti, et al.
Pageof 8